BDBM50364920 CHEMBL1950351

SMILES CCS(=O)(=O)n1c2CCN(Cc2c2cc(ccc12)C(=O)N1CCC(C)CC1)C1CCOCC1

InChI Key InChIKey=UCMNIYFDRVBMFV-UHFFFAOYSA-N

Data  4 KI  11 IC50  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 18 hits for monomerid = 50364920   

TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataEC50:  49nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 EBNA cells by [35S]GTPgamma binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataEC50:  49nMAssay Description:Agonist activity at human CB1 receptor expressed in HEK293 cells assessed as [35S]GTPgamma bindingMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibition of human Erg by voltage ion flux electrophysiological assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCytochrome P450 3A4(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of CYP3A4More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCytochrome P450 2D6(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCytochrome P450 2C19(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of CYP2C19More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCytochrome P450 1A2(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 2.00E+4nMAssay Description:Inhibition of CYP1A2More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Rat)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataEC50:  85nMAssay Description:Agonist activity at CB1 receptor in rat brain tissueMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetKappa-type opioid receptor(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human KORMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetMu-type opioid receptor(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human MORMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Mouse)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 1.90nMAssay Description:Agonist activity at CB1 receptor in field-stimulated mouse vas deferensMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetDelta-type opioid receptor(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human DORMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataKi:  9nMAssay Description:Binding affinity to human CB2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 2(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataKi:  9nMAssay Description:Binding affinity to human CB2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataKi:  120nMAssay Description:Displacement of [3H]-CP55,940 from human CB1 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/23/2012
Entry Details Article
PubMed
TargetCannabinoid receptor 1(Human)
Astrazeneca R&D Montreal

Curated by ChEMBL
LigandPNGBDBM50364920(CHEMBL1950351)
Affinity DataKi:  120nMAssay Description:Displacement of [3H]CP55940 from human CB1 receptor expressed in HEK293 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed